Scarica l'app Stockscreener
25.18
1.41%
0.35
Dopo l'orario di chiusura:
25.18
Procept Biorobotics Corp Borsa (PRCT) Ultime notizie
Does Stronger Aquablation Tailwinds And Reaffirmed 2026 Guidance Change The Bull Case For PROCEPT (PRCT)? - Sahm
PRCT SEC FilingsProcept Biorobotics Corp 10-K, 10-Q, 8-K Forms - Stock Titan
How The PROCEPT BioRobotics (PRCT) Investment Story Is Shifting After Q4 Miss And Guidance Reset - Yahoo Finance
Latest PRCT NewsPROCEPT BioRobotics Corporation Announces C... - Stock Titan
Assessing PROCEPT BioRobotics (PRCT) Valuation After Mixed Q1 2026 Results And Share Price Weakness - Sahm
PROCEPT BioRobotics Corp Q1 2026 Financial Results and SEC 10-Q Filing Highlights - Minichart
PROCEPT BioRobotics (PRCT)’s Growth Narrative Improves Following Aquablation Upgrade and HYDROS Launch - Insider Monkey
PRCT Stock Price, Quote & Chart | PROCEPT BIOROBOTICS CORP (NASDAQ:PRCT) - ChartMill
PROCEPT BioRobotics Q1 Loss Deepens To US$0.56 EPS And Tests Bullish Revenue Narratives - simplywall.st
Procept Biorobotics Charts Growth Amid Profit Pressures - TipRanks
PROCEPT BioRobotics (PRCT) CTO reports share and option stakes - Stock Titan
PROCEPT BioRobotics (NASDAQ: PRCT) Q1 2026 revenue rises 20% - Stock Titan
PROCEPT BioRobotics to Attend Three Upcoming Investor Conferences in May & June - Moomoo
PROCEPT BioRobotics schedules 3 investor conference appearances - Stock Titan
10 Best Robotics Stocks to Buy Under $30 - Insider Monkey
PROCEPT BioRobotics (NASDAQ:PRCT) Shares Gap UpStill a Buy? - MarketBeat
Vanguard (NASDAQ: PRCT) holds 2.82M shares, a 5% stake - Stock Titan
Procept projects $390M-$410M 2026 revenue as Hydros pricing guides $450K-$460K for rest of year - MSN
Procept BioRobotics price target raised to $35 from $28 at Piper Sandler - TipRanks
PROCEPT BioRobotics Corporation Q1 2026 Earnings Call Summary - Yahoo Finance
Earnings Call Summary | PROCEPT BioRobotics(PRCT.US) Q1 2026 Earnings Conference - Moomoo
PROCEPT BioRobotics (NASDAQ:PRCT) Posts Quarterly Earnings Results, Misses Estimates By $0.01 EPS - MarketBeat
PROCEPT BioRobotics Q1 Earnings Call Highlights - Yahoo Finance
PROCEPT BioRobotics Corporation (PRCT) reports Q1 loss, tops revenue estimates - MSN
Procept BioRobotics reports Q1 EPS (56c), consensus (55c) - TipRanks
Earnings call transcript: Procept Biorobotics Q1 2026 beats EPS expectations By Investing.com - Investing.com South Africa
Earnings call transcript: Procept Biorobotics Q1 2026 beats EPS expectations - Investing.com
12,200 U.S. procedures put PROCEPT BioRobotics' systems to work in Q1 - Stock Titan
PROCEPT BioRobotics Corporation (PRCT) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
PROCEPT BioRobotics Corporation (PRCT) Stock Rises on Q1 2026 Earnings - Quiver Quantitative
Earnings Flash (PRCT) PROCEPT BioRobotics Corporation Reports Q1 Revenue $83.1M, vs. FactSet Est of $80.5M - marketscreener.com
PROCEPT BioRobotics (Nasdaq: PRCT) grows Q1 2026 revenue 20% but stays loss-making - Stock Titan
PROCEPT BioRobotics Reports First Quarter 2026 Financial Results - The Manila Times
PROCEPT BioRobotics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Procept Biorobotics in the spotlight as Q1 earnings test turnaround - Investing.com UK
Procept Biorobotics in the spotlight as Q1 earnings test turnaround By Investing.com - Investing.com Australia
Robotics Stocks To Follow TodayApril 28th - MarketBeat
PROCEPT BioRobotics (PRCT) Price Target Decreased by 16.88% to 55.27 - MSN
PROCEPT BioRobotics (PRCT) price target decreased by 37.60% to 33.58 - MSN
59,200 Shares in PROCEPT BioRobotics Corporation $PRCT Bought by B. Metzler seel. Sohn & Co. AG - MarketBeat
PROCEPT BioRobotics (NASDAQ:PRCT) Rating Increased to Sell at Wall Street Zen - MarketBeat
PROCEPT BioRobotics (NASDAQ: PRCT) executive discloses initial stock and option stakes - Stock Titan
Chicago Capital Doubles Down on PROCEPT BioRobotics, Adds $27 Million in Stock - The Motley Fool
Procept BioRobotics stock rating reiterated at Buy by TD Cowen - Investing.com Australia
PRCT (PROCEPT BioRobotics Corporation) posts 37.2 percent year over year revenue growth, shares fall 4.48 percent on steep EPS miss.Product Revenue - UBND thành phố Hải Phòng
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Securities Fraud Investigation Into PROCEPT BioRobotics Corporati - The National Law Review
0.41%
0.93%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):